S
Soleno Therapeutics, Inc. (SLNO)
30.05
0.00 (0.00%)
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
30.05
0.00 (0.00%)
Soleno Therapeutics, Inc., biofarmatsevtika kompaniyasi, kam uchraydigan kasalliklarni davolash uchun yangi terapevtik vositalarni ishlab chiqish va tijoratlashtirishga qaratilgan. Uning asosiy mahsulot nomzodi VYKAT XR bo'lib, Prader-Willi sindromini davolash uchun uzaytirilgan-reliz tabletkalari. Kompaniya ilgari Capnia, Inc. nomi bilan tanilgan va 2017 yil may oyida Soleno Therapeutics, Inc. nomini o'zgartirgan. Soleno Therapeutics, Inc. 1999 yilda tashkil etilgan va Redwood City, Kaliforniyada joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Anish Bhatnagar M.D. | Chairman, President, CEO & COO |
| Dr. Michael Huang M.D. | Senior Vice President of Clinical Development |
| Dr. Neil M. Cowen M.B.A., Ph.D. | Senior Vice President of New Product Planning |
| Mr. James H. MacKaness | Executive Officer |
| Mr. Jesse Schumaker | General Counsel |
| Ms. Jennifer Fulk | Chief Financial Officer |
| Ms. Kristen Yen M.S. | Senior Vice President of Global Clinical Operations and Patient Advocacy |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-03-16 | 8-K | d107502d8k.htm |
| 2026-01-23 | 8-K | d93569d8k.htm |
| 2026-01-12 | 8-K | d18767d8k.htm |
| 2025-11-12 | 8-K | d63564d8k.htm |
| 2025-11-04 | 10-Q | slno-20250930.htm |
| 2025-10-14 | 8-K | d847935d8k.htm |
| 2025-09-10 | 8-K | d88981d8k.htm |
| 2025-08-18 | 8-K | d69752d8k.htm |
| 2025-08-06 | 10-Q | slno-20250630.htm |
| 2025-07-11 | 8-K | d52794d8k.htm |
| Ms. Lauren Budesheim |
| Senior Vice President of People |
| Ms. Meredith Manning M.B.A. | Chief Commercial Officer |
| Ms. Patricia C. Hirano M.P.H. | Senior Vice President of Regulatory Affairs |